Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: A nationwide study
Authors:
- Amytis TowfighiATAmytis Towfighi
- Daniela MarkovicDMDaniela Markovic
- Bruce OvbiageleBOBruce Ovbiagele
- 1 November 2010
- journal article
- research article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 298 (1-2) , 153-157
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary AngiographyJAMA, 2008
- Homocysteine or Renal ImpairmentArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular DiseaseJAMA, 2008
- Is homocysteine a causal and treatable risk factor for stroke?The Lancet Neurology, 2007
- Efficacy of folic acid supplementation in stroke prevention: a meta-analysisThe Lancet, 2007
- VITATOPS, the VITAmins TO Prevent Stroke Trial: Rationale and Design of a Randomised Trial of B-Vitamin Therapy in Patients with Recent Transient Ischaemic Attack or Stroke (NCT00097669) (ISRCTN74743444)International Journal of Stroke, 2007
- Effect of Folic Acid Supplementation on Risk of Cardiovascular DiseasesJAMA, 2006
- Homocysteine Lowering with Folic Acid and B Vitamins in Vascular DiseaseNew England Journal of Medicine, 2006
- Homocysteine Lowering and Cardiovascular Events after Acute Myocardial InfarctionNew England Journal of Medicine, 2006
- Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and DeathJAMA, 2004